Eli Lilly LLY announced a definitive agreement to acquire Kelonia Therapeutics in a deal valued at up to $7 billion, ...

Kura Oncology, Inc. remains a Buy, driven by ziftomenib's launch and promising combination trial data in AML. Learn more ...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel cancer therapies, today announced it will present updated data from CRDF-004, ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...

Meridian Funds, managed by ArrowMark Partners, released its first-quarter 2026 investor letter for “Meridian Small Cap Growth ...

Kura Oncology (KURA) shares rallied 8.3% in the last trading session to close at $9.68. This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...

Gilead has struck a deal to buy Germany-based Tubulis for $3.15 billion upfront and up to $1.85 billion in milestones, securing an antibody-drug conjugate (ADC) candidate that is racing toward pivotal ...

Results released April 1, 2026, by the American Society for Radiation Oncology (ASTRO), which represents more than 10,000 ...

Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership with Turbine, a leading virtual biology company, to advance ...

American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced it will ...

University of Kentucky students celebrated this year’s record-breaking DanceBlue fundraising total of $2,463,650.24, bringing the total to more than $27 million raised since it began in 2006.